Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with ENLV. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then ENLV could also see price increases.
| Ticker / NAME | Correlation To ATBPF | 1D Price Change % | ||
|---|---|---|---|---|
| ATBPF | 100% | N/A | ||
| ENLV - ATBPF | 41% Loosely correlated | N/A | ||
| SPRB - ATBPF | 39% Loosely correlated | -3.50% | ||
| APVO - ATBPF | 38% Loosely correlated | -3.53% | ||
| IGC - ATBPF | 22% Poorly correlated | -0.53% | ||
| AKTX - ATBPF | 21% Poorly correlated | +9.55% | ||
More | ||||